Commercial front door
California biotech, clinical, AI and investment relationships with reach across the US.
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Los Angeles · London · India
Senior-led · Project-scoped · Globally connected
VED helps biotech leaders decide what matters, assemble the expertise to deliver it, and adopt AI where evidence and control—not hype—justify its use.
A senior-led sprint for one clinical, regulatory or evidence question that materially changes programme value.
A fractional leader, focused expert pod or pivotal permanent hire matched to the work ahead.
Domain evaluation and controlled pilots for life-sciences AI builders and R&D adopters.
A focused commercial model
VED is not positioned as a generalist CRO or a résumé marketplace. The business begins with senior decisions clients already buy, adds verified expert delivery, and turns repeated, authorised work into better methods, evaluation structures and—only when proven—software-enabled products.
How the company is being built
Immediate revenue engine
Each engagement has a defined question, source set, owner, timetable and output. The aim is not another slide deck. It is a defensible decision the programme can execute.
Defined entry points
Start with the smallest engagement that can change the decision. Extend only when the next layer of work is justified.
10 business days
Decision memo, assumption register, risk map and a named 90-day action plan for one consequential programme question.
View the engagement 026–10 weeks
Meeting objective, questions, sponsor positions, briefing direction, rehearsal and advice implementation.
View the engagement 03Monthly
Senior regulatory or integrated-development ownership before a full-time organisation is justified.
View the engagementDelivery and reach
VED is building a focused network across the US, UK, Europe and India. Experts are matched only after relevant experience, availability, location, conflicts and engagement preferences are checked.

The scalable layer
RegulatoryX is not presented as finished software. It is the US-based route for paid AI evaluation and workflow pilots: expert-authored tasks, rubrics, failure analysis, human review and measurable acceptance criteria.
Three buying contexts
Each route explains the problem VED is equipped to solve, the most credible first engagement, and what should remain outside scope.
Move an asset through its next value inflection without carrying large-company overhead.
View your route 02Test products against realistic drug-development work, expert standards and accountable use.
View your route 03See pathway, evidence, execution and capability risk before committing capital.
View your routeOne controlled footprint
California biotech, clinical, AI and investment relationships with reach across the US.
Longstanding UK and European operating experience across globally connected programmes.
Specialist capacity used only with explicit scope, senior oversight and secure information boundaries.
Working ideas
Practical thinking on programme decisions, expert operating models and trustworthy AI adoption.
Start with the constraint
Share the situation, evidence and timing. We will propose the smallest credible first step.